| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Common Stock | Options Exercise | $0 | +8.25K | +1.12% | $0.00 | 744K | Mar 9, 2025 | Direct | F1 |
| transaction | CYRX | Common Stock | Sale | -$20.4K | -4.17K | -0.56% | $4.88 | 740K | Mar 10, 2025 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Restricted Stock Rights | Options Exercise | $0 | -8.25K | -100% | $0.00 | 0 | Mar 9, 2025 | Common Stock | 8.25K | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. |
| F2 | Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. |
| F3 | The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. |